Longevity Health Holdings, Inc. (XAGE)
2025-06-30 | 2025-03-31 | |||
|---|---|---|---|---|
| Net sales | 503,612 | 510,353 | ||
| Cost of sales | 200,954 | 240,530 | ||
| Gross profit | 302,658 | 269,823 | ||
| General and administrative | 1,564,967 | 1,275,161 | ||
| Selling and marketing | 345,505 | 280,549 | ||
| Research and development | 228,606 | 196,912 | ||
| Depreciation and amortization of intangible assets | 22,184 | 23,952 | ||
| Total operating expenses | 2,161,262 | 1,776,574 | ||
| Loss from operations | -1,858,604 | -1,506,751 | ||
| Loss on forward purchase agreement | - | - | ||
| Change in fair value of earnout liabilities | 29,630 | - | ||
| Other income | 4,357 | 5,877 | ||
| Interest expense | 2,561 | 4,993 | ||
| Amortization of debt discount | - | - | ||
| Total other income (expense) | -27,834 | 884 | ||
| Loss from continuing operations before income taxes | -1,886,438 | -1,505,867 | ||
| Income tax benefit | - | - | ||
| Loss from continuing operations | -1,886,438 | -1,505,867 | ||
| Loss from discontinued operations | - | - | ||
| Gain on sale of discontinued operations | - | - | ||
| Net loss | -1,886,438 | -1,505,867 | ||
| Basic net income (loss) per share | -1.56 | -1.52 | ||
| Diluted net income (loss) per share | -1.56 | -1.52 | ||
| Weighted average shares outstanding, basic | 1,209,809 | 991,210 | ||
| Weighted average shares outstanding, diluted | 1,209,809 | 991,210 | ||